Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synaptive

Synaptive
2012 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$75M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of neurosurgical technological products designed to offer improvement in treatment of nerve disorders. The company's products include advanced tools and information for neurosurgeons, radiologists, surgeons and hospitals to focus on patient outcomes, as well as help in surgical planning, navigation and visualization, enabling healthcare professionals to improve patient outcomes and ensure fast recovery of the patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Monitoring Equipment
Primary Office
  • 555 Richmond Street West
  • Suite 800
  • Toronto, Ontario M5V 3B1
  • Canada

+1 (647) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Synaptive’s full profile, request a free trial.

Synaptive Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 10-Dec-2019 $75M 00000 Completed Generating Revenue
4. Early Stage VC (Series A1) 28-Jun-2017 0000 000.00 00000 Completed Generating Revenue
3. Early Stage VC 01-Nov-2015 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 17-Jun-2015 $2.1M $2.99M Completed Generating Revenue
1. Angel (individual) 05-Dec-2014 $887K $887K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Synaptive Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alesi Surgical Venture Capital-Backed Cardiff, United Kingdom 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed San Jose, CA 00 000.00 000000&0 000.00
00000000 00000000 Private Equity-Backed Antioch, TN 000 000.00 000000000 000.00
00000000 Private Equity-Backed Munich, Germany 0000 0000000 0000
0000000 Venture Capital-Backed Naples, FL 0000 0000000000 0
To view this company’s complete list of competitors, request access »

Synaptive Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 09-Mar-2015 000000000000000000 Distributors (Healthcare) 0000000 00000
To view this company’s complete investment and acquisition history, request access »

Synaptive Subsidiaries (1)

Company Name Industry Location Founded
00000000000 Distributors (Healthcare) Toronto, Canada 0000
To view this company’s complete subsidiary history, request access »

Synaptive Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Linamar Corporation Minority 000 0000 000000 0
The Audible Group Accelerator/Incubator Minority 000 0000 000000 0
General Atlantic Growth/Expansion Minority 000 0000 000000 0
Quadrille Capital Venture Capital Minority 000 0000 000000 0
Epic Capital Management Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Synaptive Executive Team (20)

Name Title Board
Seat
Contact
Info
Peter Wehrly Chief Executive Officer & Chairman
Cameron Piron Co-Founder, President, Chief Strategy Officer & Board Member
Sandra Clarke Chief Financial Officer
Gal Sela Co-Founder and Director, Research & Development
Joseph Pang Director, Operations

8 Former Executives

You’re viewing 5 of 20 executives. Get the full list »

Synaptive Board Members (12)

Name Representing Role Since Contact
Info
Alex Crisses General Atlantic Board Observer 000 0000
Andrew Prozes Self Board Member 000 0000
Brad White The Audible Group Board Member 000 0000
Cameron Piron Synaptive Co-Founder, President, Chief Strategy Officer & Board Member 000 0000
David Caluori General Atlantic Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 12 board members. Get the full list »